A5039258510- Ovarian function and disorders
- Reproductive System and Pregnancy
- Reproductive Biology and Fertility
- Gestational Diabetes Research and Management
- Ectopic Pregnancy Diagnosis and Management
- Pregnancy and preeclampsia studies
- Assisted Reproductive Technology and Twin Pregnancy
- Endometriosis Research and Treatment
Sixth Affiliated Hospital of Sun Yat-sen University
2023-2025
Sun Yat-sen University
2023-2025
Kunming University of Science and Technology
2024
To investigate an optimal strategy by assessing the effectiveness of varying follicular sizes on trigger day during luteal phase stimulation protocol and provide evidence for personalized adjustment. This was a retrospective study including total 661 patients who had started their in vitro fertilization cycle with (LPS) 2015–2023. We classified into groups according to size dominant proportion follicles human chorionic gonadotropin (hCG) day: large, medium, small. The metaphase II (MII)...
Abstract Background With the increasing incidence of obesity and childbearing-age delay among women, a debate over obesity’s impacts on pregnancy neonatal outcomes becomes hot. The potential negative effects aging fertility lead to an idea, whether obese female pursuing IVF treatment can benefit from ideal BMI achieved long-time weight loss process at cost aging? We aimed assess association between body mass index (BMI) clinical or in patients undergoing vitro fertilization (IVF) treatment,...
Abstract Purpose This study evaluates the efficacy of intrauterine hCG perfusion for RIF, as defined by ESHRE 2023 guidelines, highlighting a cost-effective alternative to other immunotherapies, especially suitable less developed regions. It aims clarify treatment guidance amidst previous inconsistencies. Methods meta-analysis, registered with PROSPERO (CRD42024443241) and adhering PRISMA assessed safety in enhancing implantation pregnancy outcomes RIF. Comprehensive literature searches were...
The aims of the research were (i) to compare clinical outcome IVF using follicular-phase depot gonadotropin-releasing hormone (GnRH) agonist (depot agonist) protocol and GnRH antagonist in patients with repeated failure (RIF), (ii) discover optimal ovarian stimulation for this group low prognosis patients. 801 RIF normal reserve receiving vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) included retrospective study. Among them, 492 treated protocol, remaining 309 protocol....